Literature DB >> 16540623

MicroRNAs as therapeutic targets.

Michael P Czech1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16540623     DOI： 10.1056/NEJMcibr060065

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  37 in total

Review 1.  The emerging role of microRNAs in multiple sclerosis.

Authors:  Andreas Junker; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2010-12-14       Impact factor: 42.937

Review 2.  MicroRNA signatures in liver diseases.

Authors:  Xian-Ming Chen
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

3.  Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122.

Authors:  Daniel R Boutz; Patrick J Collins; Uthra Suresh; Mingzhu Lu; Cristina M Ramírez; Carlos Fernández-Hernando; Yufei Huang; Raquel de Sousa Abreu; Shu-Yun Le; Bruce A Shapiro; Angela M Liu; John M Luk; Shelley Force Aldred; Nathan D Trinklein; Edward M Marcotte; Luiz O F Penalva
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

4.  MicroRNA array analysis of microRNAs related to systemic scleroderma.

Authors:  Haitao Li; Rongya Yang; Xin Fan; Tingmin Gu; Zhili Zhao; Dongqing Chang; Wenling Wang; Congmin Wang
Journal:  Rheumatol Int       Date:  2010-10-30       Impact factor: 2.631

5.  High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.

Authors:  Yiming Zhou; Lijuan Chen; Bart Barlogie; Owen Stephens; Xiaosong Wu; David R Williams; Marie-Astrid Cartron; Frits van Rhee; Bijay Nair; Sarah Waheed; Mauricio Pineda-Roman; Yazan Alsayed; Elias Anaissie; John D Shaughnessy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

Review 6.  siRNA- and miRNA-based therapeutics for liver fibrosis.

Authors:  Zhen Zhao; Chien-Yu Lin; Kun Cheng
Journal:  Transl Res       Date:  2019-08-13       Impact factor: 7.012

7.  miRNA-Based Therapeutic Strategies.

Authors:  Masaharu Ishida; Florin M Selaru
Journal:  Curr Anesthesiol Rep       Date:  2012-12-24

8.  Towards computational prediction of microRNA function and activity.

Authors:  Igor Ulitsky; Louise C Laurent; Ron Shamir
Journal:  Nucleic Acids Res       Date:  2010-06-24       Impact factor: 16.971

9.  MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions.

Authors:  Sirigiri Divijendra Natha Reddy; Kazufumi Ohshiro; Suresh K Rayala; Rakesh Kumar
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

10.  Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.

Authors:  C Coulouarn; V M Factor; J B Andersen; M E Durkin; S S Thorgeirsson
Journal:  Oncogene       Date:  2009-07-20       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.